The forecasted data for antibacterial medicine use in Canada from 2024 to 2028 indicates a stable demand, with a slight increase from 10.7 units (Defined Daily Dosage) per thousand persons per day in 2024 to 10.8 units from 2025 onwards. This represents a marginal year-on-year growth, suggesting a plateau in the use of antibacterial medicines. The consistency in these values points towards a mature market with controlled growth, likely due to effective infection control measures and stewardship programs which aim to prevent antibiotic resistance.
Looking ahead, key trends to monitor include the impact of new healthcare policies on antibiotic prescription practices, advancements in antibiotic alternatives such as bacteriophage therapy or immunotherapies, and the effects of global health challenges on antibiotic demand. Additionally, public health initiatives aimed at reducing antibiotic resistance could significantly influence future usage patterns.
